130 related articles for article (PubMed ID: 26810463)
1. Polymer nanoparticle delivery of dichloroacetate and DACH-Pt to enhance antitumor efficacy and lower systemic toxicity.
Yang Q; Cai J; Sun S; Kang X; Guo J; Zhu Y; Yan L; Jing X; Wang Z
Biomater Sci; 2016 Apr; 4(4):661-9. PubMed ID: 26810463
[TBL] [Abstract][Full Text] [Related]
2. Mitaplatin, a potent fusion of cisplatin and the orphan drug dichloroacetate.
Dhar S; Lippard SJ
Proc Natl Acad Sci U S A; 2009 Dec; 106(52):22199-204. PubMed ID: 20007777
[TBL] [Abstract][Full Text] [Related]
3. A dual-targeting hybrid platinum(IV) prodrug for enhancing efficacy.
Xiao H; Yan L; Zhang Y; Qi R; Li W; Wang R; Liu S; Huang Y; Li Y; Jing X
Chem Commun (Camb); 2012 Nov; 48(87):10730-2. PubMed ID: 23012698
[TBL] [Abstract][Full Text] [Related]
4. Dual-acting antitumor Pt(iv) prodrugs of kiteplatin with dichloroacetate axial ligands.
Savino S; Gandin V; Hoeschele JD; Marzano C; Natile G; Margiotta N
Dalton Trans; 2018 May; 47(21):7144-7158. PubMed ID: 29766157
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and anticancer activity of diam(m)ine platinum(II) complexes bearing a small-molecular cell apoptosis inducer dichloroacetate.
Liu W; Jiang J; Xu Y; Hou S; Sun L; Ye Q; Lou L
J Inorg Biochem; 2015 May; 146():14-8. PubMed ID: 25706321
[TBL] [Abstract][Full Text] [Related]
6. Design of a novel theranostic nanomedicine: synthesis and physicochemical properties of a biocompatible polyphosphazene-platinum(II) conjugate.
Avaji PG; Park JH; Lee HJ; Jun YJ; Park KS; Lee KE; Choi SJ; Lee HJ; Sohn YS
Int J Nanomedicine; 2016; 11():837-51. PubMed ID: 27042052
[TBL] [Abstract][Full Text] [Related]
7. Multi-Acting Mitochondria-Targeted Platinum(IV) Prodrugs of Kiteplatin with α-Lipoic Acid in the Axial Positions.
Savino S; Marzano C; Gandin V; Hoeschele JD; Natile G; Margiotta N
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30011897
[TBL] [Abstract][Full Text] [Related]
8. Model platinum nucleobase and nucleoside complexes and antitumor activity: X-ray crystal structure of [PtIV(trans-1R,2R-diaminocyclohexane)trans-(acetate)2(9-ethylguanine)Cl]NO3.H2O.
Ali MS; Khan SR; Ojima H; Guzman IY; Whitmire KH; Siddik ZH; Khokhar AR
J Inorg Biochem; 2005 Mar; 99(3):795-804. PubMed ID: 15708801
[TBL] [Abstract][Full Text] [Related]
9. Rationally designed oxaliplatin-nanoparticle for enhanced antitumor efficacy.
Paraskar A; Soni S; Roy B; Papa AL; Sengupta S
Nanotechnology; 2012 Feb; 23(7):075103. PubMed ID: 22275055
[TBL] [Abstract][Full Text] [Related]
10. Delivery of active DACH-Pt anticancer species by biodegradable amphiphilic polymers using thiol-ene radical addition.
Xiao H; Zhou D; Liu S; Qi R; Zheng Y; Huang Y; Jing X
Macromol Biosci; 2012 Mar; 12(3):367-73. PubMed ID: 22213516
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and properties of a new micellar polyphosphazene-platinum(II) conjugate drug.
Avaji PG; Joo HI; Park JH; Park KS; Jun YJ; Lee HJ; Sohn YS
J Inorg Biochem; 2014 Nov; 140():45-52. PubMed ID: 25061690
[TBL] [Abstract][Full Text] [Related]
12. Modulatory effect of axial and equatorial ligands on antitumor activities of trans-1R,2R-diaminocyclohexane platinum(IV) complexes.
Siddik ZH; al-Baker S; Thai G; Khokhar AR
Anticancer Drug Des; 1994 Apr; 9(2):139-51. PubMed ID: 8166929
[TBL] [Abstract][Full Text] [Related]
13. Selective bio-labeling and induced apoptosis of hematopoietic cancer cells using dual-functional polyethylenimine-caged platinum nanoclusters.
Chen X; Zhou J; Yue X; Wang S; Yu B; Luo Y; Huang X
Biochem Biophys Res Commun; 2018 Sep; 503(3):1465-1470. PubMed ID: 30029883
[TBL] [Abstract][Full Text] [Related]
14. Role of carrier ligand in platinum resistance in L1210 cells.
Gibbons GR; Page JD; Mauldin SK; Husain I; Chaney SG
Cancer Res; 1990 Oct; 50(20):6497-501. PubMed ID: 2208108
[TBL] [Abstract][Full Text] [Related]
15. Targeted Drug Delivery System for Platinum-based Anticancer Drugs.
Gao C; Zhang Y; Chen J; Wang T; Qian Y; Yang B; Dong P; Zhang Y
Mini Rev Med Chem; 2016; 16(11):872-91. PubMed ID: 26586124
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and cytotoxic activity of dextran carrying cis-dichloro(cyclohexane-trans-l-1,2-diamine)platinum(II) complex.
Ohya Y; Masunaga T; Baba T; Ouchi T
J Biomater Sci Polym Ed; 1996; 7(12):1085-96. PubMed ID: 8880440
[TBL] [Abstract][Full Text] [Related]
17. Near-infrared light-mediated photoactivation of a platinum antitumor prodrug and simultaneous cellular apoptosis imaging by upconversion-luminescent nanoparticles.
Min Y; Li J; Liu F; Yeow EK; Xing B
Angew Chem Int Ed Engl; 2014 Jan; 53(4):1012-6. PubMed ID: 24311528
[TBL] [Abstract][Full Text] [Related]
18. Sensitizing nanoparticle based platinum(IV) drugs by curcumin for better chemotherapy.
Kang X; Zhao C; Yan L; Qi R; Jing X; Wang Z
Colloids Surf B Biointerfaces; 2016 Sep; 145():812-819. PubMed ID: 27311131
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of mesoporous silica nanoparticle-oxaliplatin conjugates for improved anticancer drug delivery.
He H; Xiao H; Kuang H; Xie Z; Chen X; Jing X; Huang Y
Colloids Surf B Biointerfaces; 2014 May; 117():75-81. PubMed ID: 24632033
[TBL] [Abstract][Full Text] [Related]
20. Glucose conjugated platinum(II) complex: antitumor superiority to oxaliplatin, combination effect and mechanism of action.
Li H; Gao X; Liu R; Wang Y; Zhang M; Fu Z; Mi Y; Wang Y; Yao Z; Gao Q
Eur J Med Chem; 2015 Aug; 101():400-8. PubMed ID: 26177447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
